Literature DB >> 12734728

Functional results after endoscopic subtotal cortical-sparing adrenalectomy.

Michael Brauckhoff1, Phuong Nguyen Thanh, Oliver Gimm, Annett Bär, Katrin Brauckhoff, Henning Dralle.   

Abstract

PURPOSE: We examined the required amount of residual adrenal tissue and whether an intact adrenal vein are necessary to achieve sufficient function after endoscopic subtotal adrenalectomy.
METHOD: Endoscopic subtotal adrenalectomy was performed in 14 patients. Two patients underwent unilateral subtotal and contralateral total adrenalectomy and another two patients underwent unilateral subtotal adrenalectomy after contralateral total adrenalectomy several years earlier. We analyzed the postoperative serum levels of cortisol and adrenocorticotropic hormone (ACTH). Patients with bilateral tumors underwent an ACTH test.
RESULTS: We had to cut the main adrenal vein in ten patients, and less than one third of the adrenal gland was left in situ in four patients. Subtotal adrenalectomy was performed unilaterally in two patients with bilateral tumors. One third of the adrenal gland was preserved in these patients, and also in the two patients with unilateral subtotal adrenalectomy after previous contralateral total adrenalectomy. The postoperative ACTH test confirmed satisfactory adrenocortical function. During the follow-up period of about 24 months no recurrent tumors have been found.
CONCLUSION: Subtotal cortical-sparing adrenalectomy can be successfully performed laparoscopically. The venous drainage of the main adrenal vein does not seem to be crucial for sufficient adrenocortical function. We estimate that leaving about one third of the entire adrenal gland as remnant adrenal tissue will result in sufficient function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734728     DOI: 10.1007/s005950300078

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  8 in total

1.  Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas.

Authors:  Pier Francesco Alesina; Jakob Hinrichs; Beate Meier; Kurt W Schmid; Hartmut P H Neumann; Martin K Walz
Journal:  Langenbecks Arch Surg       Date:  2011-09-21       Impact factor: 3.445

2.  Outcomes and timing for intervention of partial adrenalectomy in patients with a solitary adrenal remnant and history of bilateral phaeochromocytomas.

Authors:  Thomas H Sanford; Benjamin Barckley Storey; William Marston Linehan; Craig A Rogers; Peter A Pinto; Gennady Bratslavsky
Journal:  BJU Int       Date:  2010-08-19       Impact factor: 5.588

Review 3.  Partial adrenalectomy: underused first line therapy for small adrenal tumors.

Authors:  Deborah R Kaye; Benjamin B Storey; Karel Pacak; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-07       Impact factor: 7.450

4.  Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: results of 161 tumors in 126 patients.

Authors:  Martin K Walz; Piero F Alesina; Frank A Wenger; J Albrecht Koch; Hartmut P H Neumann; Stephan Petersenn; Kurt W Schmid; Klaus Mann
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

Review 5.  [Adrenalectomy for preservation of adrenocortical function. Indication and results].

Authors:  M K Walz
Journal:  Chirurg       Date:  2009-02       Impact factor: 0.955

6.  [Adrenal tumors].

Authors:  M K Walz
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

7.  Limitations of intraoperative adrenal remnant volume measurement in patients undergoing subtotal adrenalectomy.

Authors:  Michael Brauckhoff; Karsten Stock; Susanne Stock; Kerstin Lorenz; Carsten Sekulla; Katrin Brauckhoff; Phuong Nguyen Thanh; Oliver Gimm; Rolf Peter Spielmann; Henning Dralle
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

Review 8.  Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas.

Authors:  Aoife J Lowery; Siun Walsh; Enda W McDermott; Ruth S Prichard
Journal:  Oncologist       Date:  2013-04-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.